5.75
3.85%
-0.23
Axogen Inc. (AXGN) 最新ニュース
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
GlobeNewswire Inc.
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
GlobeNewswire Inc.
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
GlobeNewswire Inc.
Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware
Zacks Investment Research
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
4 Must-Buy Stocks for Remarkable Earnings Acceleration
Zacks Investment Research
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
Zacks Investment Research
Zacks.com featured highlights AxoGen, Western Digital and Gen Digital
Zacks Investment Research
3 Best Stocks to Buy for Remarkable Earnings Acceleration
Zacks Investment Research
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
GlobeNewswire Inc.
Here's Why Momentum in AxoGen (AXGN) Should Keep going
Zacks Investment Research
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire Inc.
Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group
Zacks Investment Research
4 Top Stocks That Flaunt Solid Earnings Acceleration
Zacks Investment Research
Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength
Zacks Investment Research
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
GlobeNewswire Inc.
Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group
Zacks Investment Research
3 Stocks Worth a Look for Solid Earnings Acceleration
Zacks Investment Research
Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday
Benzinga
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
GlobeNewswire Inc.
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
GlobeNewswire Inc.
Axogen Announces Promotions on Research and Development Team
GlobeNewswire Inc.
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
GlobeNewswire Inc.
Axogen Announces Transition of Finance Team Leadership
GlobeNewswire Inc.
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
大文字化:
|
ボリューム (24 時間):